#Switzerland #Basel #Basel Life Sciences #Korean Biopharmacy #Roche Korea

New Collaborations in Basel Area Life Sciences Supercluster

On May 5, 2026, Basel Area Business & Innovation revealed an exciting new partnership with prominent Korean biopharmaceutical companies. This strategic alliance aims to foster a stronger connection within the global biotech ecosystem by providing essential resources to high-potential firms from Korea, facilitating their entry into international markets, including the United States.

The Partnership Details

The collaboration involves notable entities such as Roche Korea, the Korea Health Industry Development Institute (KHIDI), and the Korea Technology Finance Corporation (KIBO). These organizations are committed to creating a supportive framework for innovative biopharma ventures looking to expand their influence. By combining market access, expertise, and cooperative efforts, the partnership seeks to construct a more streamlined path for Korean firms to garner global knowledge, secure capital, and tap into existing infrastructures.

Christof Klöpper, CEO of Basel Area Business & Innovation, emphasized the importance of innovation in a global context. He highlighted how the Basel Area Life Sciences Supercluster is emerging as an international gateway for biotech initiatives, enabling global companies to leverage local networks, infrastructure, and partners for growth. This initiative is set to accelerate research and development, preparing the ground for groundbreaking innovations.

Launch of an Open Innovation Program

Starting in May 2026, the partners will roll out a joint open innovation program aimed at selected companies. Each participating organization will play a specific role:

• - Roche Korea will be instrumental in selecting suitable companies and will explore funding, mentoring, and collaboration opportunities.
• - KHIDI is set to support the program's operation and identify prospective high-performing candidates.
• - KIBO will assess the companies and assist them in navigating financing options to spur their growth.
• - Basel Area Business & Innovation will ensure that these companies seamlessly integrate into the Basel life sciences ecosystem, granting them vital access to basic and advanced facilities, particularly at the Switzerland Innovation Park Basel Area.

Ezra Azem, the General Manager of Roche Korea, expressed pride in participating in this transformative project, stating that their aim is to empower promising Korean startups. By helping these innovators find their footing within the Basel Area Life Sciences Supercluster, Roche Korea plans to facilitate access to expert mentorship and resources necessary for thriving on the global stage.

Goals and Future Plans

The collaboration signifies more than just a partnership—it's a flagship program designed to bridge Korea with the international marketplace. The agreement lays the foundation for future development of the program and aims for deeper international collaboration over time, ensuring that innovative biopharma solutions can reach worldwide audiences.

About Basel Area Business & Innovation

Basel Area Business & Innovation serves as the strategic growth partner for scalable ventures in science and technology, supporting startups, scale-ups, SMEs, and global enterprises. By providing tailored insights, equity-free funding, and comprehensive support, the non-profit agency helps companies flourish within Europe's most concentrated innovation ecosystem. With direct access to valuable insights, infrastructures, and collaborative networks, companies can scale effectively in the Basel area.

In conclusion, the partnership between Basel Area Business & Innovation and the Korean biopharmaceutical community marks a significant step towards enhancing connectivity and innovation in the life sciences field. As the collaboration unfolds, it promises to generate a ripple effect of opportunities for aspiring biotech companies in both regions, ultimately benefiting global health innovation.